These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Design and synthesis of new anticancer pyrimidines with multiple-kinase inhibitory effect. El-Deeb IM, Lee SH. Bioorg Med Chem; 2010 Jun 01; 18(11):3860-74. PubMed ID: 20471842 [Abstract] [Full Text] [Related]
13. Synthesis and biological evaluation of new 1,5-diazaanthraquinones with cytotoxic activity. Manzanaro S, Vicent MJ, Martín MJ, Salvador-Tormo N, Pérez JM, del Mar Blanco M, Avendaño C, Menéndez JC, de la Fuente JA. Bioorg Med Chem; 2004 Dec 15; 12(24):6505-15. PubMed ID: 15556767 [Abstract] [Full Text] [Related]
14. The discovery of highly selective erbB2 (Her2) inhibitors for the treatment of cancer. Lippa B, Kauffman GS, Arcari J, Kwan T, Chen J, Hungerford W, Bhattacharya S, Zhao X, Williams C, Xiao J, Pustilnik L, Su C, Moyer JD, Ma L, Campbell M, Steyn S. Bioorg Med Chem Lett; 2007 Jun 01; 17(11):3081-6. PubMed ID: 17398092 [Abstract] [Full Text] [Related]
15. Inhibition of Src kinase activity by 7-[(2,4-dichloro-5-methoxyphenyl)amino]-2-heteroaryl-thieno[3,2-b]pyridine-6-carbonitriles. Boschelli DH, Wu B, Barrios Sosa AC, Chen JJ, Golas JM, Boschelli F. Bioorg Med Chem Lett; 2005 Nov 01; 15(21):4681-4. PubMed ID: 16125383 [Abstract] [Full Text] [Related]
16. Synthesis and cytotoxic activities of 4,5-diarylisoxazoles. Sun CM, Lin LG, Yu HJ, Cheng CY, Tsai YC, Chu CW, Din YH, Chau YP, Don MJ. Bioorg Med Chem Lett; 2007 Feb 15; 17(4):1078-81. PubMed ID: 17127061 [Abstract] [Full Text] [Related]
17. Synthesis and evaluation of 2,7-diamino-thiazolo[4,5-d] pyrimidine analogues as anti-tumor epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors. Lin R, Johnson SG, Connolly PJ, Wetter SK, Binnun E, Hughes TV, Murray WV, Pandey NB, Moreno-Mazza SJ, Adams M, Fuentes-Pesquera AR, Middleton SA. Bioorg Med Chem Lett; 2009 Apr 15; 19(8):2333-7. PubMed ID: 19286381 [Abstract] [Full Text] [Related]